Related Experiment Video
Updated: Sep 16, 2025

A Data-Driven Approach to Quantifying Immune States in Sepsis
Published on: February 7, 2025
Parsimonious Subphenotyping Algorithms Perform Differently in Patients With Sepsis and Hematologic Malignancy.
Lukas Ronner1, Heather M Giannini2, Todd A Miano3
1Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA.
Sepsis subphenotyping algorithms show varied performance in critically ill patients with malignancy. The IL-6 algorithm
Area of Science:
- Critical Care Medicine
- Immunology
- Oncology
Background:
- Latent class assignment algorithms can identify sepsis subgroups for targeted treatment.
- Generalizability of these algorithms to critically ill patients with comorbid malignancy is uncertain.
- Malignancy may alter inflammatory biomarkers, potentially affecting subphenotype accuracy.
Purpose of the Study:
- To evaluate if malignancy or neutropenia modifies subphenotype assignment by two algorithms.
- To assess algorithm performance in a prospective cohort of ICU patients with active malignancy.
Main Methods:
- Prospective cohort study at a single U.S. quaternary referral center.
- Included 930 ICU patients with sepsis; 396 had active malignancy.
- Applied two subphenotyping algorithms using IL-6 or IL-8, TNFR1, and bicarbonate.
Main Results:
- Hematologic malignancy patients showed higher "hyperinflammatory" assignment with the IL-8 algorithm (58%) vs. IL-6 (32%).
- Leukemia and neutropenia were overrepresented in the IL-8 hyperinflammatory group.
- Hematologic malignancy attenuated IL-6 hyperinflammatory subphenotype mortality risk (p=0.037) but not IL-8 (p=0.260).
Conclusions:
- Subphenotyping algorithms require validation in specific populations like critically ill cancer patients.
- Differential algorithm behavior in hematologic malignancy necessitates independent derivation and validation.
- Understanding generalizability is crucial as these tools are considered for point-of-care use.
More Related Videos
14:45Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
07:35Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018